NovaBay Pharmaceuticals logo

NovaBay PharmaceuticalsNYSE American: NBY

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

26 October 2007

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$2.33 M
-92%vs. 3y high
5%vs. sector
-vs. 3y high
-vs. sector
-157%vs. 3y high
9%vs. sector
-95%vs. 3y high
5%vs. sector

Price

after hours | Tue, 02 Jul 2024 23:11:41 GMT
$2.16-$0.12(-5.26%)

Dividend

No data over the past 3 years
$2.63 M$3.15 M
$2.63 M-$3.21 M

Analysts recommendations

Institutional Ownership

NBY Latest News

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
businesswire.com28 June 2024 Sentiment: -

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces it will be offering special promotions and discounts on its Avenova®-branded eyecare products to customers and eyecare professionals throughout July in support of National Dry Eye Awareness Month. National Dry Eye Awareness Month is intended to recognize the importance of eye health to overall health, and to educate the public about dry eye. The Sjögren's Foundation and its partners first asked Con.

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
businesswire.com07 June 2024 Sentiment: POSITIVE

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) announces that the NYSE American LLC (“NYSE American”) has accepted the Company's plan to regain compliance with NYSE American's continued listing standards. “I'm pleased to report on our forward momentum. By divesting an unprofitable business segment earlier this year, we're now able to focus solely on our core competency in eyecare,” said Justin Hall, CEO of NovaBay. “Unshackled by past bu.

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
businesswire.com29 May 2024 Sentiment: POSITIVE

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. the “Company”) (NYSE American: NBY) announces that a quorum was reached and that all proposals in the Company's Definitive Proxy Statement filed on April 18, 2024 with the Securities and Exchange Commission (the “SEC”) were approved by stockholders at its 2024 Annual Meeting of Stockholders held on May 28, 2024. Among the proposals, stockholders approved a reverse stock split and authorized the Company's Board of Directors to d.

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Business Wire03 May 2024 Sentiment: POSITIVE

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) will release financial results for the first quarter of 2024 after the market closes on Thursday, May 9, 2024. An investment community conference call will follow at 4:30 p.m. Eastern time on the same day. Participants can pre-register for the call by clicking the provided link.

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2023 Earnings Call Transcript
Seeking Alpha09 November 2023 Sentiment: POSITIVE

NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Jody Cain - LHA, IR Justin Hall - CEO and General Counsel Tommy Law - Interim CFO Conference Call Participants Destiny Buch - Ladenburg Thalmann Operator Welcome to the NovaBay Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
Business Wire02 November 2023 Sentiment: POSITIVE

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time: Thursday, November 9, 4:30 p.m. ET / 1:30 p.m. PT     Pre-Registration: Participants can pre-register for the conference call here:       Callers w.

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
Business Wire02 October 2023 Sentiment: POSITIVE

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that Justin Hall, CEO and General Counsel, will present a company overview and hold investor meetings at the 8th Annual Dawson James Small Cap Growth Conference being held Thursday, October 12, 2023 at the Wyndham Grand Harborside Hotel in Jupiter, Fla. “We are excited to showcase the innovative produc.

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2023 Earnings Call Transcript
Seeking Alpha12 August 2023 Sentiment: POSITIVE

NovaBay Pharmaceuticals, Inc. (NYSE:NBY ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jody Cain - LHA, IR Justin Hall - Chief Executive Officer and General Counsel Tommy Law - Interim Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to the NovaBay Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

NovaBay Pharmaceuticals to Present at the Emerging Growth Virtual Conference on May 31, 2023
Business Wire24 May 2023 Sentiment: POSITIVE

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that Justin Hall, Chief Executive Officer, will present a company overview at the Emerging Growth Virtual Conference on Wednesday, May 31, 2023 at 1:10 p.m. Eastern time (10:10 a.m. Pacific time). To attend the NovaBay presentation, submit questions in advance of the presentation and receive updates,.

NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
Business Wire04 May 2023 Sentiment: NEUTRAL

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2023 after market close on Thursday, May 11, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:   Thursday, May 11, 4:30 p.m. ET / 1:30 p.m. PT       Pre-Registration:   Participants can pre-register for the conference call here:           Callers who pre-regi.

What type of business is NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

What sector is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Healthcare sector

What industry is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Biotechnology industry

What country is NovaBay Pharmaceuticals from?

NovaBay Pharmaceuticals is headquartered in United States

When did NovaBay Pharmaceuticals go public?

NovaBay Pharmaceuticals initial public offering (IPO) was on 26 October 2007

What is NovaBay Pharmaceuticals website?

https://novabay.com

Is NovaBay Pharmaceuticals in the S&P 500?

No, NovaBay Pharmaceuticals is not included in the S&P 500 index

Is NovaBay Pharmaceuticals in the NASDAQ 100?

No, NovaBay Pharmaceuticals is not included in the NASDAQ 100 index

Is NovaBay Pharmaceuticals in the Dow Jones?

No, NovaBay Pharmaceuticals is not included in the Dow Jones index

When does NovaBay Pharmaceuticals report earnings?

Next earnings report date is not announced yet